Meta-analysis: Folic acid in the chemoprevention of colorectal adenomas and colorectal cancer

Alimentary Pharmacology and Therapeutics

Volumn 31, Issue 7, 2010, Pages 708-718

  Carroll, C ^a   Cooper, K ^a   Papaioannou, D ^a   Hind, D ^a   Tappenden, P ^a   Pilgrim, H ^a   Booth, A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CYANOCOBALAMIN; FOLIC ACID; PLACEBO; PYRIDOXINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CHEMOPROPHYLAXIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL ADENOMA; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; HIGH RISK PATIENT; HUMAN; META ANALYSIS; MONOTHERAPY; NEOPLASM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT DURATION; TUMOR RECURRENCE; ADENOMA; COLORECTAL NEOPLASMS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADENOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FOLIC ACID; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77649201763     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04238.x     Document Type: Article

References (60)

1. Bond J. Colorectal Cancer Update. Prevention, treatment, screening and surveillance for high-risk groups. Med Clin North Am 2000 84 : 1163 1182.
2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase no.5, version 2.0. Lyon : IARCPress, 2004.
3. Office for National Statistics. MB1 No. 37: Registrations of cancer diagnosed in 2006, England. Available at: http://www.statistics.gov.uk/StatBase/ Product.asp?vlnk=8843. London : 2008.
4. Welsh Cancer Intelligence and Surveillance Unit. Cancer incidence in Wales 2003-2007. Available at: http://www.wcisu.wales.nhs.uk. 2009.
5. Gionvannucci E, Stampfer M, Colditz G, et al. Folate, methionine, and alcohol intake and the risk of colorectal adenoma. J Nat Cancer Inst 1993 85 : 875 884.
6. National Institute for Health and Clinical Excellence (NICE). Guidance on Cancer Services: Improving Outcomes in Colorectal Cancers (Manual Update). NICE, London, 2004.
7. Bishop D, Hall N. The genetics of colorectal cancer. Eur J Cancer 1994 30A : 1946 1956.
8. Aaltonen L, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998 338 : 1481 1487.
9. Hill M, Morson B, Bussey H. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet 1992 8058 : 245 247.
10. Ramsoekh D, van Leerdam ME, Wagner A, Kuipers EJ. Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome). Aliment Pharmacol Ther 2007 26 (Suppl. 2 101 111.
11. Centre for Reviews and Dissemination (CRD) UoY. The management of colorectal cancers. Effective Health Care 2004 8 : 1 12.
12. Leslie A, Carey F, Pratt N, et al. The colorectal-adenoma carcinoma sequence. Br J Surgery 2002 89 : 845 860.
13. Stryker S, Wolff B, Culp C, Libbe S, Ilstrup D, MacCarty R. Natural history of untreated colonic polyps. Gastroenterology 1987 93 : 1009 1013.
14. Flossmann E, Rothwell P. British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007 369 : 1603 1613.
15. Atkin W, Saunders B. Surveillance guidelines after removal of colorectal adenomatous polyps. Gut 2002 51 (Suppl. 5 V6 9.
16. Cancer Research UK, 2008.
17. Cooper K, Pilgrim H, Carroll C, et al. Chemoprevention of colorectal cancer: systematic review and economic model. Health Technol Assess 2010 (Epub ahead of print).
18. Dube C, Rostom A, Lewin G, et al. The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007 146 : 365 375.
19. Rostom A, Dube C, Lewin G, et al. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 2007 146 : 376 389.
20. Asano T, McLeod R. Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. Cochrane Database Syst Rev 2004 2 : CD004079.
21. Weingarten M, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2008 : CD003548.
22. Shaukat A, Scouras N, Schunemann HJ. Role of supplemental calcium in the recurrence of colorectal adenomas: a meta-analysis of randomized controlled trials. Am J Gastro 2005 100 : 390 394.
23. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008 : CD004183.
24. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, Gluud C. Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther 2006 24 : 281 291.
25. Kim Y-I. Folate, colorectal carcinogenesis and DNA methylation: lessons from animal studies. Environ Mol Mutagen 2004 44 : 10 25.
26. Choi S, Mason J. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 2002 132 (S 2413S 8S.)
27. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002 132 (S 2350S 5S. (Pubitemid 34848106)
28. Sanjoaquin M, Allen N, Couto E, et al. Folate intake and colorectal cancer risk: a metaanalytical approach. Int J Cancer 2005 113 : 825 828.
29. Paspatis G, Kalafatis E, Oros L, et al. Folate status and adenomatous colonic polyps. A colonoscopically controlled study. Dis Colon Rectum 1995 38 : 64 7.
30. Baron J, Sandler R, Haile R, et al. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J Natl Cancer Inst 1998 90 : 57 62.
31. Fife J, Raniga S, Hider P, Frizelle F. Folic acid supplementation and colorectal cancer risk: a meta-analysis. Col Dis 2009 [Epub ahead of print].
32. Scottish Intercollegiate Guidelines Network. Search filters: Randomised controlled trials. Available at: http://www.sign.ac.uk/methodology/filters. html#random
33. NHS CRD. NHS Centre for Reviews and Dissemination. Report 4: Undertaking Systematic Reviews of Research on Effectiveness; CRD's Guidance for Those Carrying out or Commissioning Reviews. New York : University of York, 2009.
34. Review Manager (RevMan). [Computer Program]. Version 5.0. Copenhagen : The Nordic Cochrane Centre, The Cochrane Collaboration 2008.
35. Montori V, Guyatt G. Intention-to-treat principle. CMAJ 2001 165 : 1339 1341.
36. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials BMJ 1999 319 : 670 674.
37. Logan R, Grainge M, Shepherd E, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008 134 : 29 38.
38. Cole B, Baron J, Sandler R, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007 297 : 2351 2359.
39. Zhang S, Cook N, Albert C, et al. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 2008 300 : 2012 2021.
40. Zhu S, Mason J, Yaol S, et al. The effect of folic acid on the development of stomach and other gastrointestinal cancers. Chin Med J 2003 116 : 15 9.
41. Baron J, Cole B, Sandler R, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003 348 : 891 899. (Pubitemid 36297997)
42. Cole B, Baron J, Sandler R, et al. A randomized trial of folic acid to prevent colorectal adenomas. Proc Am Assoc Cancer Res Annu Meet 2005 46 : 4399.
43. Zhu S, Mason J, Shi Y, et al. The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers - Clinical trial and follow-up for seven years. Chinese Journal of Gastroenterology 2002 7 : 73 8.
44. Jaszewski R, Misra S, Tobi M, et al. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial. World J Gastroenterol 2008 14 : 4492 4498.
45. Lonn E, Yusuf S, Arnold J, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. New Eng J Med 2006 354 : 1567 1577.
46. Lonn E, Held C, Arnold J, et al. Rationale, design and baseline characteristics of a large, simple, randomised trial of combined folic acid and vitamin B6 and B12, in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol 2006 22 : 47 53.
47. Tierney J, Stewart L. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 2005 34 : 79 87.
48. Figueiredo J, Grau M, Halle R, et al. Folic acid and risk of prostate cancer: results from a randomized controlled trial. J Natl Cancer Inst 2009 1010 : 432 435.
49. Ulrich C, Potter J. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006 15 : 189 193.
50. Bjelakovic G, Nikolova D, Simonetti R, et al. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004 364 : 1219 1228.
51. Kim Y.-I. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 2004 80 : 1123 1128.
52. +/Min mouse during early neonatal life. Brit J Nutr 2008 99 : 550 558.
53. Mathers J. Folate intake and bowel cancer risk. Genes Nutr 2009 4 : 173 178.
54. Mason J, Dickstein A, Jacques P, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007 16 : 1325 1329.
55. Smith A, Kim Y-I, Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008 87 : 517 533.
56. Kim Y-I. Folic acid supplementation and cancer risk. Point. Cancer Epidemiol Biomarkers Prev 2008 17 : 2220 2225.
57. Ulrich C. Folate and cancer prevention - Where to next? Counterpoint Cancer Epidemiol Biomarkers Prev 2008 17 : 2226 2230.
58. Eichholzer M, Tonz O, Zimmerman R. Folic acid: a public health challenge. Lancet 2006 367 : 1352 1361.
59. McGauran A. UK food agency reaffirms its advice that addition of folic acid to flour should be compulsory. BMJ 2009 339 : b4369.
60. Tedstone A, Browne M, Harrop L, et al. Fortification of selected foodstuffs with folic acid in the UK: consumer research carried out to inform policy recommendations. J Public Health 2008 30 : 23 9.